Current ADA standards of care (SOC) include recommendations for T2D patients with cardiorenal conditions. Research shows clinical inertia towards implementation of evidence-based guidelines. The study aimed to gain insight into clinician attitudes, knowledge and behavior related to the ADA SOC. Eligible clinicians (PCPs, Endos and PA/NPs) caring for T2D patients were identified from the Healthcare Integrated Research Database based on claims submitted for <u>></u>5 T2D patients during the study period, 11/30/2019 - 11/30/2021. A survey assessed clinician attitudes and knowledge. ADA SOC behavior was determined by 6 claims-based therapeutic management (TM) measures including A1c and eGFR/UACR testing; statin, GLP-1 and SGLT2 prescribing. High knowledge was defined as answering ≥80% of knowledge questions correctly; high TM metric attainment was defined as ≥75th percentile attainment for each measure. Survey responses and claims-based TM metrics were linked for each respondent. Of 402 respondents, 260 (65%) were PCPs, 44 (11%) Endos and 98 (24%) PA/NPs. Clinician attitudes regarding cardiorenal aspects of the ADA SOC were positive and did not vary by clinician type. High knowledge scores were reported by 58% of PCPs, 77% of Endos and 60% of PA/NPs. Correlation coefficients between attitudes and TM metric attainment ranged from -0.04 - 0.15 and between knowledge and TM metric attainment ranged from -0.03 - 0.14. The most common pattern observed between knowledge and TM metric attainment was high knowledge/low TM measure attainment, followed closely by a low/low pattern. Clinician attitudes were positive and showed adequate knowledge of the cardiorenal ADA SOC. Correlation between ADA SOC attitudes and knowledge and claims-based TM metric attainment were low. Opportunities exist to provide guideline-focused medical education for PCPs and PA/NPs coupled with interventions at the point of care to translate guideline knowledge into improved evidence-based care.

Disclosure

V. Willey: Other Relationship; Carelon Research. J.J. Stephenson: None. L.J. Seman: None. N. Witkowski: Employee; Boehringer-Ingelheim. A.C.Y. Wong: Employee; Boehringer-Ingelheim. J.L. Smith: Employee; Elevance Health. Stock/Shareholder; Elevance Health. L. Bengtson: Employee; Boehringer-Ingelheim, Optum.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.